Page 192 - AACN Essentials of Critical-Care Nursing Pocket Handbook, Second Edition

179

Prolonged paralysis in pseudocholinesterase deficiencies pressure increased serum potassium concentration Metabolized by pseudocholinesterase Intubating dose: initial 0.15 mg/kg followed in 30 seconds by 0.1 mg/kg

Comments Contraindications: Family history of malignant hyperthermia, neuromuscular disease, hyperkalemia, open eye injury, major tissue injury (burns, trauma, crush), increased intracranial Side effects: bradycardia (especially in children),

Neuromuscular Blocking Agents Onset/Duration Dose Onset: 1 minutes Intubating dose: Duration: 10 minutes 1-2 mg/kg Onset: 5 minutes Intubating dose: Duration: 15-20 minutes 0.25 mg/kg Duration: 15 minutes Maintenance dose: 0.1 mg/kg Conti

Agent Depolarizing Agents Succinylcholine Nondepolarizing Agents Short-Acting Mivacurium
7.2